Treatment and follow up of children with chronic hepatitis C in Albania

Virology Journal

Volumn 9, Issue , 2012, Pages

  Velmishi, Virtut ^a   Dervishi, Ermira ^a   Cullufi, Paskal ^a   Bali, Donjeta ^a   Durro, Vjollca ^b  

^a UNIVERSITY HOSPITAL CENTER MOTHER TERESA   (Albania)

^b Ministry of Health   (Albania)

Author keywords

Chronic Hepatitis C = CHC; ETVR = End Treatment Viral Response; HCV = Hepatitis C Virus; SVR = Sustained Viral Response

Indexed keywords

ALBINTERFERON ALPHA2B; PEGINTERFERON ALPHA2B; RIBAVIRIN; ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; RECOMBINANT PROTEIN; VIRUS RNA;

ADOLESCENT; ALBANIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PRESCHOOL CHILD; PROSPECTIVE STUDY; RELAPSE; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME; BLOOD; ORAL DRUG ADMINISTRATION; RECURRENT DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION;

HEPATITIS C VIRUS;

ADMINISTRATION, ORAL; ADOLESCENT; ALBANIA; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERON-ALPHA; MALE; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RECURRENCE; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME;

EID: 84855750484     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-17     Document Type: Article

References (32)

1. Controversies in the management of pediatric liver disease: Hepatitis B, C and NAFLD: summary of a single topic conference. Schneider BL, Gonzalez-Peralta R, Roberts EA, Hepatology 2006 44 1344 1354 10.1002/hep.21373 17058223 (Pubitemid 44748385)
2. Children with HCV infection show high sustained virologic response rates on peginterferon -2b plus ribavirin treatment. Wirth S, Ribes-Koninckx C, Bortolotti F, et al. Hepatology 2008 48 392A
3. Design of the PEDS-C trial: pegylated interferon ribavirin for children with chronic hepatitis C viral infection. Murray KF, Rodrigue JR, Gonzalez-Peralta RP, et al. Clin Trials 2007 4 661 673 10.1177/1740774507085445 18042575 (Pubitemid 351567522)
4. Peginterferon with or without ribavirin for chronic hepatitis C in children and adolescents: final results of the PEDS-C trial. Schwarz KB, Gonzalez-Peralta RP, Murray KF, et al. Hepatology 2008 48 Suppl. 1 418A
5. An analysis of published trials of Interferon monotherapy in children with chronic hepatitis C. Jacobson KR, Murray K, Zellos A, Schwarz KB, J Pediatr Gastroenterol Nutr 2002 34 52 58 10.1097/00005176-200201000-00013 11753165 (Pubitemid 34251703)
6. Interferon a2b treatment in children with chronic HCV hepatitis. Jara P, Hierro L, Frauca E, et al. J Pediatr Gastroenterol Nutr 1997 24 487
7. Recombinant interferon- therapy in children with chronic hepatitis C. Bortolotti F, Giacchino R, Vajro P, et al. Hepatology 1995 22 1623 1627 10.1002/hep.1840220602 7489965
8. Lymphoblastoid interferon a treatment in chronic hepatitis C. Iorio R, Pensati P, Porzio S, Fariello I, Guida S, Vegnente A, Arch Dis Child 1996 74 152 156 10.1136/adc.74.2.152 8660080 (Pubitemid 26057699)
9. Interferon treatment in children with chronic hepatitis C: long-lasting remission in responders, and risk for disease progression in non-responders. Bortolotti F, Iorio R, Nebbia G, et al. Digest Liver Dis 2005 37 336 341 10.1016/j.dld.2004.12.010 (Pubitemid 44382334)
10. Recombinant -interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C. Wirth S, Lang T, Gehring S, Gerner P, Hepatology 2002 36 1280 1284 10.1053/jhep.2002.36495 12395341 (Pubitemid 35253447)
11. Interferon -2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics. Gonzalez-Peralta RP, Kelly DA, Haber B, et al. Hepatology 2005 42 1010 1018 Study on efficacy and toxicity of combined IFN- plus ribavirin treatment in a large population of children 10.1002/hep.20884 16250032 (Pubitemid 43112667)
12. The safety, efficacy, and pharmacokinetics of peginterferon -2a (40 kD) in children with chronic hepatitis C. Schwarz KB, Mohan P, Narkewicz M, et al. J Pediatr Gastroenterol Nutr 2006 43 499 505 10.1097/01.mpg.0000235974.67496.e6 17033526 (Pubitemid 44569011)
13. Sero epidemiological study of hepatitis C in Albania blood donors. Durro V, Koraqi A, Kokonoshi V, Nurka T, et al. XV regional Congress of ISBT, Europe, Abstract book, P Athine July 2005 187 2005
14. Children with hepatitis C. Jonas MM, Hepatology 2002 36 173 S178 12407591
15. The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders. Posthouwer D, Fischer K, van Erpecum KJ, Mauser-Bunschoten EP, Transfusion 2006 46 1360 1366 10.1111/j.1537-2995. 2006.00903.x 16934072 (Pubitemid 44117964)
16. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Locasciulli A, Testa M, Pontisso P, et al. Blood 1997 90 4628 4633 9373275 (Pubitemid 27508470)
17. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood donor screening. Vogt M, Lang T, Froesner G, et al. N Engl J Med 1999 341 866 870 10.1056/NEJM199909163411202 10498458 (Pubitemid 29427048)
18. Chronic hepatitis C in children: the pathological and clinical spectrum. Guido M, Rugge M, Jara P, et al. Gastroenterology 1998 115 1525 1529 Description of histology in pediatric chronic hepatitis C children unaffected by any other disease 10.1016/S0016-5085(98)70032-0 9834281 (Pubitemid 28546004)
19. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. European Paediatric Hepatitis C Virus Network, Clin Infect Dis 2005 41 45 51 15937762
20. Serum levels of HCV RNA in infants and children with chronic hepatitis C. Azzari C, Resti M, Bortolotti F, et al. J Pediatr Gastroenterol Nutr 1999 29 314 317 10.1097/00005176-199909000-00014 10467998 (Pubitemid 30366141)
21. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Kenny-Walsh E, for the Irish Hepatology Research Group, N Engl J Med 1999 340 1228 1233 10.1056/NEJM199904223401602 10210705 (Pubitemid 29181642)
22. Chronic hepatitis C in childhood: a 18-year experience. Iorio R, Giannattasio A, Sepe A, Terracciano MA, Vecchione R, Vegnente A, Clin Infect Dis 2005 41 1431 1437 10.1086/497141 16231253 (Pubitemid 41579984)
23. Diagnosis, management, and treatment of hepatitis C: an update. Ghany MG, Strader DB, Thomas DL, Seeff LB, American Association for the Study of Liver Diseases, Hepatology 2009 49 1335 1374 10.1002/hep.22759 19330875
24. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. Mast EE, Hwang LY, Seto DS, et al. J Infect Dis 2005 192 1880 1889 10.1086/497701 16267758 (Pubitemid 41681885)
25. Guidelines for care of pregnant women carrying hepatitis C virus and their infants. Shiraki K, Ohto H, Inaba N, et al. Pediatr Int 2008 50 138 140 10.1111/j.1442-200X.2007.02518.x 18279227 (Pubitemid 351239398)
26. When does mother to child transmission of HCV occur? Mok J, Pembrey L, Tovo PA, Newell ML, for the European Pediatric HCV Network, Arch Dis Child Fetal Neonatal Ed 2005 90, F156 F160 15724041
27. Spontaneous clearance of childhood hepatitis C virus infection. Yeung LT, To T, King SM, Roberts EA, J Viral Hepat 2007 14 797 805 10.1111/j.1365-2893. 2007.00873.x 17927616 (Pubitemid 47561585)
28. Viral kinetics in hepatitis C virus: special patient populations. Layden-Almer JE, Layden TJ, Semin Liver Dis 2003 23 Suppl. 1 29 33 12934166 (Pubitemid 37052442)
29. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Wiese M, Berr F, Lafrenz M, Porst H, Oesen U, for the East German Hepatitis C Study Group, Hepatology 2000 32 91 96 10869294 (Pubitemid 30432371)
30. Efficacy and safety of PEG-IFN-2b and ribavirin combination therapy in children with chronic hepatitis C. Jara P, Hierro L, de la Vega A, et al. Pediatr Infect Dis J 2008 27 142 148 Experience of currently recommended therapy in Spanish children 18174875
31. PEG-IFN plus ribavirin treatment in children and adolescents with chronic hepatitis C. Wirth S, Pieper-Boustani H, Lang T, et al. Hepatology 2005 41 1013 1018 Experience of currently recommended therapy in German children 10.1002/hep.20661 15793840 (Pubitemid 40593909)
32. The Italian Observatory for HCV infection and hepatitis C in children. Epidemiological profile of 806 Italian children with HCV infection over a 15-year period. Bortolotti F, Iorio R, Resti M, et al. J Hepatol 2007 46 783 790 10.1016/j.jhep.2006.12.014 17321633 (Pubitemid 46529042)